Each year approximately 8000 and 5000 women respectively experience allergi
c rhinitis and asthma during pregnancy in Switzerland. Frequently the sympt
oms require pharmacotherapy. However, due to the lack of controlled studies
no asthma and allergy medication has been proven safe for use during pregn
ancy. In this review a therapeutic approach is presented, based on the medi
cal literature, to the use of pharmacotherapy in the management of allergic
rhinitis and asthma during pregnancy.